Provention Bio (PRVB) Competitor Comparison
We are evaluating the key criteria listed to compare Provention Bio (PRVB) against its competitors in the Biotechnology industry.
Market Capitalization
71 / 368Gross Profits
210 / 278Total Revenue
178 / 300EBITDA
229 / 337Free Cashflow
35 / 352Quick Ratio
296 / 357Earnings per Share
173 / 359Dividend yield
0 / 6Total Cash
180 / 358Performance 3 years
41 / 368Performance 5 years
43 / 368Performance 10 years
38 / 368Linearity 3 years
341 / 368Linearity 5 years
348 / 368Linearity 10 years
342 / 368Total Rank
239 / 368Dividend Rank
249 / 368Valuation Rank
46 / 368Piotroski Rank
100 / 368Muliplier Rank
185 / 368Performance 3 years - PRVB ranking 41 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.